The company issued ordinary shares at $6.59 apiece, the same price as its previous financing from CDC Group and Ascent Myanmar Growth Fund in 2019, according to Accounting and Corporate Regulatory Authority (ACRA) filings accessed by DealStreetAsia – DATA VANTAGE.
Continue reading this story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at firstname.lastname@example.org